These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4781249)

  • 41. Non-invasive techniques in assessing left ventricular performance in congestive cardiomyopathy.
    Lewis BS; Armstrong TG; Samson RI; Everson RC; Van der Horst RL; Gotsman MS
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():699-715. PubMed ID: 4806995
    [No Abstract]   [Full Text] [Related]  

  • 42. Vasodilator therapy in chronic congestive heart failure.
    Schwartz AB; Chatterjee K
    Drugs; 1983 Aug; 26(2):148-73. PubMed ID: 6349967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term use of vasodilator agents].
    Luomanmaki K; Frick MH
    Duodecim; 1982; 98(2):139-49. PubMed ID: 7060511
    [No Abstract]   [Full Text] [Related]  

  • 44. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
    Daly PA; Chatterjee K; Viquerat CE; Parmley WW; Curran D; Scheinbaum M; Anderson S
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1539-44. PubMed ID: 4003296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aortic input impedance in heart failure: comparison with normal subjects and its changes during vasodilator therapy.
    Merillon JP; Fontenier G; Lerallut JF; Jaffrin MY; Chastre J; Assayag P; Motte G; Gourgon R
    Eur Heart J; 1984 Jun; 5(6):447-55. PubMed ID: 6745286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventricular afterload reduction in management of congestive heart failure--a rational new concept that has rapidly come of age by vasodilator drugs.
    Mason DT
    Clin Cardiol; 1978 Aug; 1(2):55-9. PubMed ID: 756817
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of nitroprusside on hydraulic vascular loads on the right and left ventricle of patients with heart failure.
    Yin FC; Guzman PA; Brin KP; Maughan WL; Brinker JA; Traill TA; Weiss JL; Weisfeldt ML
    Circulation; 1983 Jun; 67(6):1330-9. PubMed ID: 6851029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of aortic impedance on left ventricular function in aortic stenosis.
    Khalilullah M; Sethi KK
    Indian Heart J; 1982; 34(3):125-7. PubMed ID: 7129488
    [No Abstract]   [Full Text] [Related]  

  • 50. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 51. [Mechanism of action and clinical use of vasodilators in acute heart insufficiency].
    Rothlin ME
    Schweiz Rundsch Med Prax; 1985 Dec; 74(49):1372-5. PubMed ID: 4081449
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of vasodilators in congestive heart failure.
    Conti CR; Mehta J; Pepine CJ; Nichols WW
    Adv Cardiol; 1980; 27():313-21. PubMed ID: 6778088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How much can we expect from vasodilator therapy in congestive heart failure?
    Zelis R; Flaim SF; Moskowitz RM; Nellis SH
    Circulation; 1979 Jun; 59(6):1092-7. PubMed ID: 436201
    [No Abstract]   [Full Text] [Related]  

  • 54. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction.
    Chatterjee K; Parmley WW; Ganz W; Forrester J; Walinsky P; Crexells C; Swan HJ
    Circulation; 1973 Dec; 48(6):1183-93. PubMed ID: 4762476
    [No Abstract]   [Full Text] [Related]  

  • 55. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 56. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
    Solignac A
    Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathophysiology of cardiac failure.
    Weber KT; Janicki JS; Maskin CS
    Am J Cardiol; 1985 Jul; 56(3):3B-7B. PubMed ID: 4025157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy of cardiac output, oxygen uptake, and arteriovenous oxygen difference at rest, during exercise, and after vasodilator therapy in patients with severe, chronic heart failure.
    Rubin SA; Siemienczuk D; Nathan MD; Prause J; Swan HJ
    Am J Cardiol; 1982 Nov; 50(5):973-8. PubMed ID: 7137048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of acute and chronic congestive heart failure by vasodilator-afterload reduction.
    Mason DT; Awan NA; Joye JA; Lee G; DeMaria AN; Amsterdam EA
    Arch Intern Med; 1980 Dec; 140(12):1577-81. PubMed ID: 6257193
    [No Abstract]   [Full Text] [Related]  

  • 60. Recent advances in vasodilator therapy. Part I: physiologic correlations.
    Aranda JM; Linares E; Hernández-López E; Cintrón G; Song S
    Bol Asoc Med P R; 1981 Jan; 73(1):3-10. PubMed ID: 7020713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.